XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.21.1

Other Liabilities | 3 Months Ended
--- | ---
Mar. 31, 2021
Other Liabilities Disclosure [Abstract] |
Other Liabilities | Other Liabilities Other liabilities consisted of the following:
(in thousands) |  | As of March 31, 2021 |  | As of December 31, 2020
Employee compensation and benefits |  | $ | 36,614 |  |  | $ | 34,020 |
Deferred FCC repack income |  | 44,442 |  |  | 44,945 |
Programming liability |  | 207,093 |  |  | 33,481 |
Liability for pension benefits |  | 154,212 |  |  | 161,845 |
Liabilities for uncertain tax positions |  | 21,760 |  |  | 2,332 |
Liability for common stock warrants |  | 248,084 |  |  | — |
Other |  | 27,116 |  |  | 9,742 |
Other liabilities (less current portion) |  | $ | 739,321 |  |  | $ | 286,365 |
In connection with the acquisition of ION, we assumed $19.3 million of uncertain tax position liabilities. Approximately $15.1 million of the liability is attributed to disallowed domestic production activities deductions (DPAD). We currently expect this DPAD liability will be resolved through settlement, amendments and/or payment within the next twelve months. With the Preferred Shares issuance, Berkshire Hathaway also received a warrant to purchase up to 23.1 million Class A shares, at an exercise price of $13 per share. The warrant is exercisable at the holder's option at any time or from time to time, in whole or in part, until the first anniversary of the date on which no Preferred Shares remain outstanding. Since the holder has the option to settle the warrant through cash payment of the exercise price and/or through surrendering portions of their Preferred Shares for the stated par value, a liability must be recognized for the fair value of the warrant. The valuation model, classified within Level 3 of the fair value hierarchy, includes inputs for the estimated term of the warrant, the historical volatility rate of Scripps common stock and the exercise price for the warrant. At time of issuance, the fair value of the warrant totaled $181 million. The fair value of the warrant is remeasured each reporting period and totaled $248 million at March 31, 2021. The increase in our stock price during 2021 was the primary contributor to the increase in the fair value of the warrant. Change in the fair value of the warrant during each reporting period is captured in the gains/ losses on stock warrants caption in the Condensed Consolidated Statements of Operations.

X
- References No definition available. + Details
Name: | us-gaap_OtherLiabilitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_OtherLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration